Intuitive Surgical, Inc. $ISRG Position Lifted by Greenup Street Wealth Management LLC

Greenup Street Wealth Management LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1,108.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 6,927 shares of the medical equipment provider’s stock after acquiring an additional 6,354 shares during the period. Greenup Street Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,817,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical during the 2nd quarter worth $1,335,753,000. Arrowstreet Capital Limited Partnership raised its position in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Assenagon Asset Management S.A. raised its position in Intuitive Surgical by 55.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after purchasing an additional 558,099 shares during the last quarter. Amundi raised its position in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Finally, Temasek Holdings Private Ltd boosted its stake in shares of Intuitive Surgical by 416.4% during the first quarter. Temasek Holdings Private Ltd now owns 227,211 shares of the medical equipment provider’s stock valued at $104,742,000 after purchasing an additional 183,211 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. TD Cowen reiterated a “buy” rating and issued a $485.00 price objective on shares of Intuitive Surgical in a report on Monday, October 19th. Leerink Partners set a $503.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 21st. Wells Fargo & Company reiterated an “overweight” rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Insider Transactions at Intuitive Surgical

In related news, Director Craig H. Barratt sold 1,150 shares of the company’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $510,370.00. Following the sale, the director owned 1,150 shares in the company, valued at $510,370. This represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 38,778 shares of company stock worth $16,814,967. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Down 3.7%

Shares of NASDAQ ISRG opened at $432.01 on Friday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The firm has a fifty day simple moving average of $401.54 and a 200 day simple moving average of $434.05. The company has a market capitalization of $149.75 billion, a PE ratio of 52.24, a P/E/G ratio of 3.09 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.40 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.